GlaxoSmithKline Pharmaceuticals Limited
Pharmaceuticals & BiotechnologyISIN: INE159A01016
Held By
23 funds
16% of 147 tracked
Avg Weight
0.66%
across all holders
Max Weight
2.83%
NIPPON INDIA PHARMA FUND
Categories
6
fund categories
Mutual Funds Holding GlaxoSmithKline Pharmaceuticals Limited (23)
Category Breakdown
Equity - Other11 funds
Mid Cap7 funds
Large & Mid Cap2 funds
Sectoral - Pharma1 funds
Dividend Yield1 funds
Multi Cap1 funds